Cargando…
Assessment of 24,25(OH)2D levels does not support FGF23-mediated catabolism of vitamin D metabolites
Progressive elevations of fibroblastic growth factor 23 [FGF23] in chronic kidney disease may reduce serum 25-hydroxyvitamin D [25(OH)] and 1,25-dihydroxyvitamin D [1,25(OH)2D] levels, via stimulation of 24-hydroxylase (Cyp24A1) mediated catabolism of these vitamin D metabolites. To test this possib...
Autores principales: | Dai, Bing, David, Valentin, Alshayeb, Hala M., Showkat, A., Gyamlani, G, Horst, Ronald L., Wall, Barry M., Quarles, L. Darryl |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3461248/ https://www.ncbi.nlm.nih.gov/pubmed/22739976 http://dx.doi.org/10.1038/ki.2012.222 |
Ejemplares similares
-
Multiple Sclerosis Patients Show Lower Bioavailable 25(OH)D and 1,25(OH)(2)D, but No Difference in Ratio of 25(OH)D/24,25(OH)(2)D and FGF23 Concentrations
por: Vlot, Mariska C, et al.
Publicado: (2019) -
The serum 24,25-dihydroxyvitamin D concentration, a marker of vitamin D catabolism, is reduced in chronic kidney disease
por: Bosworth, Cortney, et al.
Publicado: (2012) -
Effects of 1,25 and 24,25 Vitamin D on Corneal Epithelial Proliferation, Migration and Vitamin D Metabolizing and Catabolizing Enzymes
por: Lu, Xiaowen, et al.
Publicado: (2017) -
24,25-Dihydroxy Vitamin D and Vitamin D Metabolite Ratio as Biomarkers of Vitamin D in Chronic Kidney Disease
por: Lee, Seunghye, et al.
Publicado: (2023) -
Serum 24,25-dihydroxyvitamin D level in general Korean population and its relationship with other vitamin D biomarkers
por: Kim, Hyun-Ki, et al.
Publicado: (2021)